Prolonged 3-year spontaneous remission of diffuse large B-cell lymphoma upon withdrawal of infliximab and late relapse in a patient with psoriasis: a case report and review of the literature

Leuk Lymphoma. 2023 Oct;64(10):1695-1700. doi: 10.1080/10428194.2023.2232488. Epub 2023 Jul 26.

¹ Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
² Department of Pathology, Evangelismos Hospital, Athens, Greece.
³ First Department of Pathology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
⁴ Department of Nuclear Medicine and PET/CT, Evangelismos Hospital, Athens, Greece.
⁵ Second Department of Surgery, Propedeutic, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
⁶ Department of Pathophysiology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.

No abstract available

Keywords: anti-TNFα; apremilast; diffuse large B-cell lymphoma; infliximab; novel biologic agent; psoriasis.

Publication types